Podcast with board member Ted Fjällman
On a recent episode of Värdeskaparna, NorthX Biologics very own board member Ted Fjällman made a quest appearance. During the podcast, Ted delves into the biotech industry’s current trends and ...
NorthX Biologics is providing expert plasmid DNA solutions for all phases ranging from early pre-clinical through to commercial manufacture. We offer a range of plasmid qualities with the right level of control for every purpose, ensuring efficient expedition of your program with full regulatory compliance. We are providing pDNA as critical starting material for viral vector gene therapies and mRNA applications but also complete drug product manufacturing including aseptic fill/finish for pDNA vaccines and other modalities.
By applying our flexible proprietary platform process we can deliver high quality plasmids with compressed timelines facilitating speed to market. We are using aligned processes ensuring scalability from small to large scale with full in-house analytical support. In our modern innovation labs, we are providing full development services to meet you specific needs for optimization and process adaptions. By applying a structured R&D model we help to mitigate later manufacturing risks.
Read more by clicking the link below.
NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.
For more news, follow us on LinkedIn
On a recent episode of Värdeskaparna, NorthX Biologics very own board member Ted Fjällman made a quest appearance. During the podcast, Ted delves into the biotech industry’s current trends and ...
We’re thrilled to share that Janet Hoogstraate, the CEO of NorthX Biologics, has recently appeared in an episode of Q-podden! 🎧 In this engaging podcast, Janet discusses the latest trends and innovations ...
On behalf of the Swedish Ministry for Foreign Affairs and Gavi, the Global Vaccine Alliance, NorthX Biologics’ CEO Janet Hoogstraate participated in an important roundtable on “Leveraging Technology and Innovation to Ensure Every ...